A phase 1/2 clinical trial of AAV8 gene therapy in adults with late-onset OTC deficiency: CAPtivate cohort 1+2 results

被引：0
|
作者：
Geberhiwot, T. [1 ]
Aldamiz-Echevarria, L. [2 ]
Couce, M. L. [3 ]
Diaz, G. A. [4 ]
Harding, C. O. [5 ]
Khan, A. [6 ]
Tan, W. H. [7 ]
Lee, C. [8 ]
Puga, A. C. [8 ]
Crombez, E. [8 ]
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Cruces Univ Hosp, Biocruces Bizkaia Hlth Res Inst, Baracaldo, Spain
[3] Univ Santiago de Compostela, Santiago De Compostela, Spain
[4] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[5] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[6] Univ Calgary, Calgary, AB, Canada
[7] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA
[8] Ultragenyx Gene Therapy, Novato, CA USA
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
OR49
引用
收藏
页码：A18 / A18
页数：1
相关论文
共 50 条
  • [41] Phase 1 Study of Gene Therapy in Late-Onset Pompe Disease: Analyses of Safety and Secondary Endpoints
    Koeberl, Dwight
    Smith, Edward C.
    Case, Laura
    Hopkins, Sam
    Childers, Martin K.
    Dearmey, Stephanie
    Walters, Crista
    Han, Sang-oh
    Spears, Tracy G.
    Hornik, Christoph P.
    Bali, Deeksha
    Kishnani, Priya S.
    MOLECULAR THERAPY, 2020, 28 (04) : 224 - 224
  • [42] Subretinal Gene Therapy in Patients with Bietti Crystalline Dystrophy: Preliminary Results of a Phase 1/2 Clinical Trial
    Yin, Shiyi
    Zhang, Haihan
    Chen, Jieqiong
    Wang, Jinyuan
    Li, Yang
    Yang, Qiong
    Sha, Ying
    Lv, Hua
    Zhao, Xiaoping
    Guan, Ning
    Chen, Ruixue
    Mao, Hongxia
    Sun, Xiaodong
    Wei, Wenbin
    MOLECULAR THERAPY, 2024, 32 (04) : 81 - 82
  • [43] SPK-8016: PRELIMINARY RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF GENE THERAPY FOR HEMOPHILIA A
    Sullivan, S. K.
    Barrett, J. C.
    Drelich, D. A.
    Tarantino, M. D.
    MacDougall, A.
    Joseney-Antoine, M.
    Wachtel, K.
    Jaworski, K.
    Curran, M.
    Kuranda, K.
    Armour, S. M.
    Mingozzi, F.
    Anguela, X. M.
    Reape, K. Z.
    Monahan, P. E.
    High, K. A.
    HAEMOPHILIA, 2021, 27 : 129 - 130
  • [44] Hematopoietic Stem Cell Gene Therapy for Cystinosis: Updated Results from a Phase 1/2 Clinical Trial
    Cherqui, Stephanie
    MOLECULAR THERAPY, 2022, 30 (04) : 29 - 29
  • [45] Phase 1 Study of Gene Therapy in Late-Onset Pompe Disease: Initial 104-Week Experience
    Smith, Edward C.
    Hopkins, Sam
    Case, Laura E.
    Childers, Martin K.
    Han, Sang-Oh
    Spears, Tracy G.
    Hornik, Christoph P.
    Bali, Deeksha
    Kishnani, Priya S.
    Koeberl, Dwight D.
    MOLECULAR THERAPY, 2022, 30 (04) : 563 - 564
  • [46] Phase 1/2 study update of an AAV9-based gene therapy for Gaucher disease type 2 (PROVIDE trial)
    Neuhaus, Sarah
    Lewis, Travis B.
    Tamburri, Paul A.
    Whitley, Chester B.
    Rajan, Deepa
    Gallagher, Renata C.
    Jones, Simon
    Donald, Aimee
    Escolar, Maria L.
    Beckerman, Yael
    Mahoney, Erin
    Hatch, Daniel A.
    Shaughnessy, Lee
    Sondergaard, Patricia
    Uspenskaya, Olga
    Sevigny, Jeffrey
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 93 - 93
  • [47] Efficacy and safety of AAV2 gene therapy in children with aromatic L-amino acid decarboxylase deficiency: an open-label, phase 1/2 trial
    Chien, Yin-Hsiu
    Lee, Ni-Chung
    Tseng, Sheng-Hong
    Tai, Chun-Hwei
    Muramatsu, Shin-ichi
    Byrne, Barry J.
    Hwu, Wuh-Liang
    LANCET CHILD & ADOLESCENT HEALTH, 2017, 1 (04): : 265 - 273
  • [48] Spk-8011: Preliminary Results from a Phase 1/2 Dose Escalation Trial of an Investigational AAV-Mediated Gene Therapy for Hemophilia a
    George, Lindsey A.
    Ragni, Margaret V.
    Samelson-Jones, Ben J.
    Cuker, Adam
    Runoski, Alexa R.
    Cole, Grace
    Wright, Fraser
    Chen, Yifeng
    Hui, Daniel J.
    Wachtel, Katie
    Takefman, Daniel
    Couto, Linda B.
    Reape, Kathleen Z.
    Carr, Marcus E.
    Anguela, Xavier M.
    High, Katherine A.
    BLOOD, 2017, 130
  • [49] Long-term, sustained efficacy and safety from a phase 1/2 clinical trial of an AAV8-mediated liver-directed gene therapy in adults with glycogen storage disease type Ia
    Pico, M. L. Couce
    Mitchell, J.
    Ahmad, A.
    Olmos, M.
    Derks, T. G.
    Riba-Wolman, R.
    Weinstein, D. A.
    Rodriguez-Buritica, D. F.
    Lee, C.
    Valayannopoulos, V.
    Crombez, E.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A28 - A28
  • [50] Choroideremia Gene Therapy Phase 2 Clinical Trial: 24-Month Results
    Lam, Byron L.
    Davis, Janet L.
    Gregor, Ninel Z.
    Maclaren, Robert E.
    Girach, Aniz
    Verriotto, Jennifer D.
    Rodriguez, Belen
    Rosa, Potyra R.
    Zhang, Xiaojun
    Feuer, William J.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 197 : 65 - 73
12345